For clinicians
Supporting, not replacing, your judgement
In routine practice, assessment of depression relies on careful listening, structured questioning and experience. LumetrixDx has been developed to complement this work by providing a standardised, objective view of brain activity associated with depression.
Following validation and regulatory approval, LumetrixDx will offer:
At every stage, LumetrixDx is intended as a decision support tool. Clinical diagnosis and management decisions remain with the treating clinician.
A typical workflow:
LumetrixDx builds on a body of research suggesting that certain EEG patterns in frontal brain regions differ, on average, between people with major depressive disorder and healthy controls, and may change with treatment.
Our development programme includes:
Depression is a complex, heterogeneous condition. No single test can capture every dimension of a person’s experience, and no algorithm is perfect.
LumetrixDx is designed around clear principles:
Ethics approvals, data protection measures and risk management are integral to all of our research studies.
Get in touch to purchase LumetrixDx for your clinic.
We are actively seeking:
If you would like to discuss potential collaboration or stay informed about upcoming studies, please contact us or register your interest using the form below.